(redirected from malignancies)
Also found in: Dictionary, Thesaurus, Medical, Legal.


see cancercancer,
in medicine, common term for neoplasms, or tumors, that are malignant. Like benign tumors, malignant tumors do not respond to body mechanisms that limit cell growth.
..... Click the link for more information.
References in periodicals archive ?
There was a male predilection amongst patients presenting with oral and maxillofacial malignancies with a male to female ratio 2.
Abstract #2510, Poster Discussion Session: Genitourinary Malignancies (Hall C2)
TK is a well validated target in B-cell malignancies and data from our pre-clinical studies indicates that BGB-3111 may demonstrate a superior efficacy and safety profile compared to the market leading BTK inhibitor.
5-16 years) presenting with different hematological malignancies were enrolled.
Results: Hundred histologically diagnosed skin malignancies were reported during the period under review.
26 Cappelli et al16 study showed that considering thyroid tumors of larger than 10mm resulted in not detecting 19% of malignancies.
Methods: Data of all the biopsy proven malignancies of gastrointestinal tract was retrieved from individual case files from the record of Pathology Department.
4) Yao and colleagues (4) performed a literature review from 1985 to 2008 and found 32 case reports of malignancy in RS3PE, including 18 solid tumors, 11 hematologic malignancies, and 3 additional malignancies of unknown sites.
The concomitant presence of malignancies with rheumatic diseases may appear in various forms: (i) metastasis to musculoskeletal system (ii) non-metastatic paraneoplastic rheumatic diseases (iii) malignancies secondary to a rheumatic disease (iv) malignancies which developed as complications due to immunosuppressive drugs used for the treatment of rheumatic diseases (v) rheumatic diseases which developed as complications from malignancy treatments.
The agency has asked manufacturers of tumor necrosis factor blockers to enhance their follow-up of pediatric and young adult patients who develop malignancies while on these treatments.
Managing infections in patients with hematological malignancies.